GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » EV-to-EBIT

Abbott India (BOM:500488) EV-to-EBIT : 34.54 (As of Jun. 07, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Abbott India's Enterprise Value is ₹563,017 Mil. Abbott India's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹16,302 Mil. Therefore, Abbott India's EV-to-EBIT for today is 34.54.

The historical rank and industry rank for Abbott India's EV-to-EBIT or its related term are showing as below:

BOM:500488' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.31   Med: 26.12   Max: 46.62
Current: 34.53

During the past 13 years, the highest EV-to-EBIT of Abbott India was 46.62. The lowest was 11.31. And the median was 26.12.

BOM:500488's EV-to-EBIT is ranked worse than
77.84% of 668 companies
in the Drug Manufacturers industry
Industry Median: 16.43 vs BOM:500488: 34.53

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Abbott India's Enterprise Value for the quarter that ended in Mar. 2024 was ₹551,125 Mil. Abbott India's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹16,302 Mil. Abbott India's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.96%.


Abbott India EV-to-EBIT Historical Data

The historical data trend for Abbott India's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India EV-to-EBIT Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.00 31.35 31.88 34.98 33.81

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.98 35.43 32.31 31.33 33.81

Competitive Comparison of Abbott India's EV-to-EBIT

For the Drug Manufacturers - General subindustry, Abbott India's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Abbott India's EV-to-EBIT falls into.



Abbott India EV-to-EBIT Calculation

Abbott India's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=563016.601/16301.5
=34.54

Abbott India's current Enterprise Value is ₹563,017 Mil.
Abbott India's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16,302 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (BOM:500488) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Abbott India's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=16301.5/551125.4378
=2.96 %

Abbott India's Enterprise Value for the quarter that ended in Mar. 2024 was ₹551,125 Mil.
Abbott India's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16,302 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Abbott India's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines